Article Details
Retrieved on: 2022-06-27 20:05:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR), a commercial-stage biopharmaceutical company focused on the development of ...
Article found on: www.prnewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here